| Original language | English |
|---|---|
| Pages (from-to) | 27-30 |
| Number of pages | 4 |
| Journal | Cancer Biology and Therapy |
| Volume | 8 |
| Issue number | 1 |
| DOIs |
|
| State | Published - Jan 2009 |
Keywords
- Cisplatin
- Mutation
- Ovarian
- PI3K
- Taxane
- Taxol
- Therapy
PI3K: A rational target for ovarian cancer therapy?
Paul Dent, Steven Grant, Paul B. Fisher, David T. Curiel
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Department of Radiation Oncology
- Center of Regenerative Medicine
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Molecular Genetics and Genomics
- Brain Tumor Center
Research output: Contribution to journal › Comment/debate
7
Scopus
citations